4Q 2018 Results and preliminary annual report

01. Mar 2019 | 1 min read

Moss, 28 February 2019
 
Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results. The highlights include:
 
  • Record sales revenues of MNOK 11.1 for the quarter
  • 42 % growth in underlying sales revenue compared to 4Q17, 43 % year to date
  • All time high sales results achieved with fCAL® turbo

 

 
Please find the report here:  GDAS 2018 4Q Interim report[2594] or on Oslo Børs NewsWeb.
 
For further information, please contact:
 
Hilja Ibert
CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242
 
Njaal Kind
CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525

You may also read


Apr 30, 2025 - Kristin Hart

Gentian Diagnostics: Invitation to presentation of first quarter results

Gentian Diagnostics ASA will present its first quarter 2025 results on 7 May 2025 at 10.00 CEST.

Read more

Apr 11, 2025 - Ole Sørlie

Gentian Diagnostics: Notice of annual general meeting

Gentian Diagnostics ASA’s annual general meeting will be held on Tuesday 6 May 2025 at 11:00 at the company’s..

Read more

Apr 07, 2025 - Kristin Hart

Mandatory notification of trade

Moss, 7 April 2025

Read more